These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26558729)
21. TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial. Laurens MB; Mungwira RG; Nyirenda OM; Divala TH; Kanjala M; Muwalo F; Mkandawire FA; Tsirizani L; Nyangulu W; Mwinjiwa E; Taylor TE; Mallewa J; Blackwelder WC; Plowe CV; Laufer MK; van Oosterhout JJ Trials; 2016 Jul; 17(1):322. PubMed ID: 27431995 [TBL] [Abstract][Full Text] [Related]
22. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial. Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628 [TBL] [Abstract][Full Text] [Related]
23. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. Achan J; Kakuru A; Ikilezi G; Ruel T; Clark TD; Nsanzabana C; Charlebois E; Aweeka F; Dorsey G; Rosenthal PJ; Havlir D; Kamya MR N Engl J Med; 2012 Nov; 367(22):2110-8. PubMed ID: 23190222 [TBL] [Abstract][Full Text] [Related]
24. Effects of cotrimoxazole prophylaxis on Jiang J; Qin F; Meng S; Nehl EJ; Huang J; Liu Y; Zou J; Dong W; Huang J; Chen H; Zang N; Liang B; Ning C; Liao Y; Luo C; Liu H; Liu X; Wang J; Zhou O; Le T; Ye L; Wu F; Liang H Emerg Microbes Infect; 2019; 8(1):367-376. PubMed ID: 31851879 [TBL] [Abstract][Full Text] [Related]
25. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. Ku SW; Jiamsakul A; Joshi K; Pasayan MKU; Widhani A; Chaiwarith R; Kiertiburanakul S; Avihingsanon A; Ly PS; Kumarasamy N; Do CD; Merati TP; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Khusuwan S; Sim BLH; Ng OT; Ratanasuwan W; Ross J; Wong WW; J Int AIDS Soc; 2019 Mar; 22(3):e25264. PubMed ID: 30924281 [TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa. Choi SE; Brandeau ML; Bendavid E Malar J; 2017 Oct; 16(1):403. PubMed ID: 28985732 [TBL] [Abstract][Full Text] [Related]
27. Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon. Janssen S; Hermans S; Knap M; Moekotte A; Rossatanga EG; Adegnika AA; Bélard S; Hänscheid T; Grobusch MP PLoS Negl Trop Dis; 2015 May; 9(5):e0003769. PubMed ID: 25993501 [TBL] [Abstract][Full Text] [Related]
28. Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial. Manirakiza A; Tondeur L; Ketta MYB; Sepou A; Serdouma E; Gondje S; Bata GGB; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Briand V; Lombart JP; Vray M Trop Med Int Health; 2021 Oct; 26(10):1314-1323. PubMed ID: 34407273 [TBL] [Abstract][Full Text] [Related]
29. The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis. Juma DW; Muiruri P; Yuhas K; John-Stewart G; Ottichilo R; Waitumbi J; Singa B; Polyak C; Kamau E PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007223. PubMed ID: 30897090 [TBL] [Abstract][Full Text] [Related]
30. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995 [TBL] [Abstract][Full Text] [Related]
31. Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis. Mbeye NM; ter Kuile FO; Davies MA; Phiri KS; Egger M; Wandeler G; Trop Med Int Health; 2014 Sep; 19(9):1057-67. PubMed ID: 25039469 [TBL] [Abstract][Full Text] [Related]
32. Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes. Francis F; Gough EK; Edens TJ; Berejena C; Bwakura-Dangarembizi M; Shonhai A; Nathoo KJ; Glass M; Gibb DM; Prendergast AJ; Manges AR J Acquir Immune Defic Syndr; 2020 Dec; 85(5):601-605. PubMed ID: 32852361 [TBL] [Abstract][Full Text] [Related]
33. Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy. Kyosiimire-Lugemwa J; Anywaine Z; Abaasa A; Levin J; Gombe B; Musinguzi K; Kaleebu P; Grosskurth H; Munderi P; Pala P J Infect Dis; 2020 Jul; 222(3):381-390. PubMed ID: 31714954 [TBL] [Abstract][Full Text] [Related]
34. Frequent malaria illness episodes in two Malawian patients on antiretroviral therapy soon after stopping cotrimoxazole preventive therapy. Nyangulu WJ; Mwinjiwa E; Divala TH; Mungwira RG; Nyirenda O; Kanjala M; Mbambo G; Mallewa J; Taylor TE; Laurens MB; Laufer MK; van Oosterhout JJ Malawi Med J; 2017 Mar; 29(1):57-60. PubMed ID: 28567199 [TBL] [Abstract][Full Text] [Related]
35. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. Natureeba P; Ades V; Luwedde F; Mwesigwa J; Plenty A; Okong P; Charlebois ED; Clark TD; Nzarubara B; Havlir DV; Achan J; Kamya MR; Cohan D; Dorsey G J Infect Dis; 2014 Dec; 210(12):1938-45. PubMed ID: 24958908 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial. Kamya MR; Kapisi J; Bigira V; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Kakuru A; Aweeka FT; Huang L; Jagannathan P; Achan J; Havlir DV; Rosenthal PJ; Dorsey G AIDS; 2014 Nov; 28(18):2701-9. PubMed ID: 25493596 [TBL] [Abstract][Full Text] [Related]
37. Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review. Saadani Hassani A; Marston BJ J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S306-17. PubMed ID: 25768870 [TBL] [Abstract][Full Text] [Related]